<DOC>
	<DOCNO>NCT01987323</DOCNO>
	<brief_summary>Aim : Evaluation single subconjunctival injection liposomal EggPC formulation latanoprost treat glaucoma . Hypothesis : The investigator already evaluate carrier stability , drug partitioning , vitro drug release , tolerance , efficacy latanoprost-incorporated EggPC liposomes upon subconjunctival administration rabbit monkey eye . Therefore , investigator hypothesize would safe efficacious human well . Methodology : A pilot study assess liposome formulation contain latanoprost . The investigator recruit 6 study subject eye raise IOP , subconjunctival injection liposome formulation . The recruited eye inject monitored inflammation , toxicity pain primary end-points . Monitoring eye first 24 hour post-injection , week 2 , month 1 , 2 3 thereafter . Importance : If prove safe , method drug delivery could potentially use treatment raise intraocular pressure blind condition glaucoma .</brief_summary>
	<brief_title>Safety Efficacy Liposomal Latanoprost Ocular Hypertension</brief_title>
	<detailed_description>The number record adverse event intolerance subconjunctival injection procedure participant study period use measure safety .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<criteria>Glaucoma patient eye raise IOP ( baseline IOP &gt; 21 mmHg ) due endstage glaucoma poor visual prognosis . Exclusion criterion : 1 . Active recent eye infection , endophthalmitis 2 . Known hypersensitivity latanoprost 3 . Only eye 4 . Previous glaucoma filtration surgery trabeculectomy 5 . Intraocular pressure less 12mmHg . 6 . Inability give inform consent . 7 . Inability safely administer subconjunctival injection 8 . Uncontrolled systemic hypertension , CVA TIA within previous month . 9 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>raise intraocular pressure</keyword>
</DOC>